GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » YoY EBITDA Growth

Baskhanbiopharma (XKRX:354390) YoY EBITDA Growth : 42.79% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Baskhanbiopharma's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 42.79%.

Baskhanbiopharma's EBITDA per Share for the six months ended in Dec. 2024 was ₩690.80.

Baskhanbiopharma YoY EBITDA Growth Historical Data

The historical data trend for Baskhanbiopharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma YoY EBITDA Growth Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
- 313.54 -4.96 83.70 42.79

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth - 313.54 -4.96 83.70 42.79

Baskhanbiopharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Baskhanbiopharma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(690.801-483.78)/ | 483.78 |
=42.79 %

Baskhanbiopharma's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 ) |
=(690.801-483.78)/ | 483.78 |
=42.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baskhanbiopharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:018620 XKRX:318010 XKRX:034940 XKRX:233250 XKRX:336040 XKRX:018680 XKRX:900120 XKRX:053950 XKRX:200230 XKRX:314140 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Website
https://www.baskhanbio.com
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines